Velaxin (venlafaxine) in the treatment of anxious depression

被引：0
|
作者：
Ilyina, N. A. [1 ]
机构：
[1] Sci Ctr Mental Hlth, Moscow, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2008年 / 108卷 / 03期
关键词：
velaxin; therapy; anxious depression;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Thirty patients (7 mate, 23 female) mean age 35,3 +/- 7,8 years with anxious or anxious-apathic depression, including 24 in-patients and 6 out-patients. They were treated during 8 weeks with velaxin in dosage 225-375 mg per day. The changes of patient state evaluated with rating scales (CGI, HDRS, BDI, HADS-21). Twenty-seven patients (90%) completely underwent the course of treatment. Responders according to CGI were 25 (83,3%) cases: "improvement" - 16 (59,3%), "apparent improvement" - 9 (33,3%); "minor improvement" - 2 (7,4%) patients. The complete reduction of depressive symptoms was recorded in 33,3% of cases. The safety of velaxin in moderate therapeutic doses as well as improvement of laboratory and instrumental characteristics of somatic state was confirmed.
引用
收藏
页码：24 / 28
页数：5
相关论文
共 50 条
  • [1] Experience of the use of velaxin (venlafaxine) in anxious depression
    Il'ina N.A.
    [J]. Neuroscience and Behavioral Physiology, 2009, 39 (3) : 305 - 309
  • [2] Venlafaxine (velaxin) effectivity in treatment of depression: results of the recent investigations
    Veltishchev, D. Yu
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (11) : 81 - 83
  • [3] Efficacy of Venlafaxine (Velaxin) in the Treatment of Depression: Results of Recent Trials
    Vel’tishchev D.Y.
    [J]. Neuroscience and Behavioral Physiology, 2015, 45 (5) : 576 - 578
  • [4] Anxiolytic effects of venlafaxine/olanzapine combination in treatment of anxious depression
    Kulhan, Tomas
    Marcincakova Husarova, Veronika
    Ondrejka, Igor
    Farsky, Ivan
    Nosalova, Gabriela
    [J]. NEUROENDOCRINOLOGY LETTERS, 2017, 38 (08) : 579 - 585
  • [5] Comparison of the efficacy of venlafaxine, selective serotonin reuptake inhibitors, and placebo in the treatment of patients with anxious depression
    Fava, M
    Entsuah, R
    Tummala, R
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S101 - S101
  • [6] Comparative efficacy of sertraline versus venlafaxine-XR in anxious depression
    Vahip, S
    D'Souza, R
    Sir, A
    Hopwood, M
    George, T
    Yerli, E
    Burt, T
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S198 - S198
  • [7] Venlafaxine in the treatment of postpartum depression
    Cohen, LS
    Viguera, AC
    Bouffard, SM
    Nonacs, RM
    Morabito, C
    Collins, MH
    Ablon, JS
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (08) : 592 - 596
  • [8] Anxious depression and response to treatment
    Nelson, J. Craig
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (03): : 297 - 299
  • [9] MOTIVAL IN TREATMENT OF ANXIOUS DEPRESSION
    FALENI, R
    CIA, A
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1972, 14 (08): : 461 - &
  • [10] Alprazolam/venlafaxine versus venlafaxine in the treatment of mixed depression and anxiety
    Jakovcevska-Kujundziska, M.
    Lazarova, V.
    Filovska, V.
    Cadikovska, N.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S589 - S589
12345